A subscription to JoVE is required to view this content. Sign in or start your free trial.
This work describes the synthesis and characterization of a pomalidomide-based, bifunctional homo-PROTAC as a novel approach to induce ubiquitination and degradation of the E3 ubiquitin ligase cereblon (CRBN), the target of thalidomide analogs.
The immunomodulatory drugs (IMiDs) thalidomide and its analogs, lenalidomide and pomalidomide, all FDA approved drugs for the treatment of multiple myeloma, induce ubiquitination and degradation of the lymphoid transcription factors Ikaros (IKZF1) and Aiolos (IKZF3) via the cereblon (CRBN) E3 ubiquitin ligase for proteasomal degradation. IMiDs have recently been utilized for the generation of bifunctional proteolysis targeting chimeras (PROTACs) to target other proteins for ubiquitination and proteasomal degradation by the CRBN E3 ligase. We designed and synthesized pomalidomide-based homobifunctional PROTACs and analyzed their ability to induce self-directed ubiquitination and degradation of CRBN. Here, CRBN serves as both, the E3 ubiquitin ligase and the target at the same time. The homo-PROTAC compound 8 degrades CRBN with a high potency with only minimal remaining effects on IKZF1 and IKZF3. CRBN inactivation by compound 8 had no effect on cell viability and proliferation of different multiple myeloma cell lines. This homo-PROTAC abrogates the effects of IMiDs in multiple myeloma cells. Therefore, our homodimeric pomalidomide-based compounds may help to identify CRBN‘s endogenous substrates and physiological functions and investigate the molecular mechanism of IMiDs.
The immunomodulatory drugs (IMiDs) thalidomide and its analogs, lenalidomide and pomalidomide, all approved for the treatment of multiple myeloma, bind to the E3 ubiquitin ligase cereblon (CRBN), a substrate adaptor for cullin4A-RING E3 ubiquitin ligase (CRL4CRBN)1,2,3. Binding of IMiDs enhances the affinity of CRL4CRBN to the lymphoid transcription factors Ikaros (IKZF1) and Aiolos (IKZF3), leading to their ubiquitination and degradation (Figure 1)4,5,....
1. Preparation of PROTAC molecules
CAUTION: Please consult all relevant material safety data sheets (MSDS) before use. Several of the chemicals used in these syntheses are toxic and carcinogenic. Please use all appropriate safety practices and personal protective equipment.
Here we described the design, synthesis and biological evaluation of a homodimeric pomalidomide-based PROTAC for the degradation of CRBN. Our PROTAC interacts simultaneously with two CRBN molecules and forms ternary complexes that induces self-ubiquitination and proteasomal degradation of CRBN with only minimal remaining effects on pomalidomide-induced neo-substrates IKZF1 or IKZF3.
Out of a series of previously published pomali.......
The design of such homo-PROTACs as described here for CRBN relies on the specific affinity of pomalidomide to CRBN, which has been successfully utilized in numerous heterobifunctional PROTACs and resulted in the development of PROTAC 8 as a highly selective CRBN degrader. The specificity of our molecule has already been confirmed by proteomic analyses24. For genetically mediated knockout, exclusion and validation of side effects is challenging and time consuming. In addition, a ch.......
This work was supported by the Deutsche Forschungsgemeinschaft (Emmy-Noether Program Kr-3886/2-1 and SFB-1074 to J.K.; FOR2372 to M.G.)
....Name | Company | Catalog Number | Comments |
1,1'-Carbonyldiimidazole | TCI chemicals | C0119 | |
2,2′-(Ethylenedioxy)-bis(ethylamine) | Sigma-Aldrich | 385506 | Compound 6 |
2-Mercaptoethanol | Sigma-Aldrich | M6250 | |
3-Fluorophthalic anhydride, 98 % | Alfa Aesar | A12275 | |
4-Dimethylaminopyridine, 99 % | Acros | 148270250 | Toxic |
Acrylamidstammlösung/ Bisacrylamid (30%/0,8%) | Carl Roth | 3029.1 | |
Aiolos (D1C1E) mAB | Cell signaling | 15103S | |
Anti-CRBN antibody produced in rabbit | Sigma | HPA045910 | |
Anti-rabbit IgG HRP-linked antibody | Sigma | 7074S | |
Ammonium Persulfate | Roth | 9592.2 | |
Boc-Gln-OH | TCI chemicals | B1649 | |
Bovine Serum Albumin | Sigma-Aldrich | A7906-100G | |
CellTiter-Glo Luminescent Cell Viability Assay | Promega | G7571 | |
ChemiDoc XRS+ | Bio-Rad | 1708265 | |
DMF, anhydrous, 99.8 % | Acros | 348435000 | Extra Dry over Molecular Sieve |
DMSO, anhydrous, 99.7 % | Acros | 348445000 | Extra Dry over Molecular Sieve |
Glycine | Sigma-Aldrich | 15523-1L-R | |
Goat anti-mouse (HRP conjugated) | Santa Cruz biotechnology | sc-2005 | |
Halt Protease & Phosphatase Inhibitor Single-use Cocktail (100X) | Thermo Scientific | 1861280 | |
Ikaros (D6N9Y) Mab | Cell signaling | 14859S | |
ImmobilonP Transfer Membrane (0,45µm) | Merck | IPVH000010 | |
Iodomethane, 99 % | Sigma-Aldrich | I8507 | Highly toxic |
Methanol | Sigma-Aldrich | 32213-2.5L | |
Mg132 | Selleckchem | S2619 | |
Mini Trans-Blot electrophoretic transfer cell | Bio-Rad | 1703930 | |
Mini-PROTEAN Tetra Vertical Electrophoresis Cell | Bio-Rad | 1658004 | |
MLN4942 | biomol (cayman) | Cay15217-1 | |
Monoclonal Anti-α-Tubulin antibody produced in mouse (B512) | Sigma | T5168 | |
N-Ethyldiisopropylamine, 99 % | Alfa Aesar | A11801 | |
Nonfat dried milk powder | PanReac AppliChem | A0830,0500 | |
Nunc F96 MicroWell White Polystyrene Plate | Thermo Scientific | 136101 | |
NuPAGE LDS Sample Buffer (4X) | Thermo Scientific | NP0008 | |
Pierce BCA Protein Assay kit | Thermo Scientific | 23225 | |
Pomalidomide | Selleckchem | S1567 | |
RestoreTM Western Blot Stripping Buffer | Thermo Scientific | 46430 | |
sodium dodecyl sulfate | Carl Roth | 183.1 | |
Sodium Chloride | Sigma-Aldrich | A9539-500g | |
TEMED | Carl Roth | 2367.3 | |
tert-Butyl N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]carbamate | Sigma-Aldrich | 89761 | Compound 5 |
Tricin | Carl Roth | 6977.4 | |
Trizma base | Sigma-Aldrich | T1503-1kg | |
Tween-20 | Sigma-Aldrich | P7949-500ml | |
WesternBright ECL spray | Advansta | K-12049-D50 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved